GGrantIndex
← Leaderboards

Adetunji T Toriola

Washington University

$10,614,775
Attributed
$24,601,793
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY201225
$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,601,793 · 7

By mechanism

U01$12,936,006 · 1
R37$4,228,391 · 1
T32$2,633,601 · 1
UG1$2,291,995 · 1
R01$1,768,982 · 1
R21$742,818 · 2

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Innovation

Research focus

InnovationMalignant NeoplasmsParticipantWomanRecruitEnrollmentBiological MarkersBloodFollow-UpScreeningMolecularIncidenceIndexingDiagnosisPathway InteractionsMalignant Breast NeoplasmInterestQuestionnairesMammographyBreast Cancer PreventionBreast Cancer Risk FactorChemopreventionAgedBlood Specimen

Grant awards (33)

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,724,414
U01 · FY2025 · CA
Building equity in cancer screening through research: The Siteman Catchment CSRN Hub$874,688
UG1 · FY2025 · CA
Surgical Oncology Basic Science and Translational Research Training Program$624,527
T32 · FY2025 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$599,882
R37 · FY2025 · CA · contact PI
Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub$542,621
UG1 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,364
U01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$91,144
U01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,788,840
U01 · FY2024 · CA
Building equity in cancer screening through research: The Siteman Catchment CSRN Hub$874,686
UG1 · FY2024 · CA
Surgical Oncology Basic Science and Translational Research Training Program$616,670
T32 · FY2024 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$569,887
R37 · FY2024 · CA · contact PI
Metabolite Profiles and Mammographic Density in Premenopausal Women$342,268
R01 · FY2024 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,210
U01 · FY2024 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,848,714
U01 · FY2023 · CA
Surgical Oncology Basic Science and Translational Research Training Program.$715,584
T32 · FY2023 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$595,446
R37 · FY2023 · CA · contact PI
Metabolite Profiles and Mammographic Density in Premenopausal Women$353,076
R01 · FY2023 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,670,811
U01 · FY2022 · CA
Surgical Oncology Basic Science and Translational Research Training Program.$676,820
T32 · FY2022 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$617,956
R37 · FY2022 · CA · contact PI
Metabolite Profiles and Mammographic Density in Premenopausal Women$353,076
R01 · FY2022 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,936,657
U01 · FY2021 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$624,067
R37 · FY2021 · CA · contact PI
Metabolite Profiles and Mammographic Density in Premenopausal Women$360,281
R01 · FY2021 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,967,702
U01 · FY2020 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$627,245
R37 · FY2020 · CA · contact PI
Metabolite Profiles and Mammographic Density in Premenopausal Women$360,281
R01 · FY2020 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,717,150
U01 · FY2019 · CA
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention$593,908
R37 · FY2019 · CA · contact PI
RANK PATHWAY AND MAMMOGRAPHIC DENSITY IN MID-LIFE WOMEN$171,505
R21 · FY2018 · CA · contact PI
RANK PATHWAY AND MAMMOGRAPHIC DENSITY IN MID-LIFE WOMEN$204,466
R21 · FY2017 · CA · contact PI
EFFECT OF WEIGHT LOSS ON BONE HEALTH IN POSTMENOPAUSAL BREAST CANCER SURVIVORS$160,127
R21 · FY2013 · CA · contact PI
EFFECT OF WEIGHT LOSS ON BONE HEALTH IN POSTMENOPAUSAL BREAST CANCER SURVIVORS$206,720
R21 · FY2012 · CA · contact PI